SG11201603170YA - Crystalline solvate forms of cabazitaxel - Google Patents

Crystalline solvate forms of cabazitaxel

Info

Publication number
SG11201603170YA
SG11201603170YA SG11201603170YA SG11201603170YA SG11201603170YA SG 11201603170Y A SG11201603170Y A SG 11201603170YA SG 11201603170Y A SG11201603170Y A SG 11201603170YA SG 11201603170Y A SG11201603170Y A SG 11201603170YA SG 11201603170Y A SG11201603170Y A SG 11201603170YA
Authority
SG
Singapore
Prior art keywords
cabazitaxel
solvate forms
crystalline solvate
crystalline
forms
Prior art date
Application number
SG11201603170YA
Inventor
Walter Cabri
Daniele Ciceri
Luca Domenighini
Andrea Gambini
Federico Peterlongo
Original Assignee
Indena Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Indena Spa filed Critical Indena Spa
Publication of SG11201603170YA publication Critical patent/SG11201603170YA/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D305/00Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SG11201603170YA 2013-10-23 2014-10-09 Crystalline solvate forms of cabazitaxel SG11201603170YA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP20130189944 EP2865674A1 (en) 2013-10-23 2013-10-23 Crystalline solvate forms of Cabazitaxel
PCT/EP2014/071596 WO2015058960A1 (en) 2013-10-23 2014-10-09 Crystalline solvate forms of cabazitaxel

Publications (1)

Publication Number Publication Date
SG11201603170YA true SG11201603170YA (en) 2016-05-30

Family

ID=49447492

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201603170YA SG11201603170YA (en) 2013-10-23 2014-10-09 Crystalline solvate forms of cabazitaxel

Country Status (13)

Country Link
US (1) US20160257663A1 (en)
EP (2) EP2865674A1 (en)
JP (1) JP2016534066A (en)
KR (1) KR20160074508A (en)
CN (1) CN105722832A (en)
AU (1) AU2014339221A1 (en)
BR (1) BR112016007595A2 (en)
CA (1) CA2928304A1 (en)
IL (1) IL245259A0 (en)
MX (1) MX2016005229A (en)
RU (1) RU2016115559A (en)
SG (1) SG11201603170YA (en)
WO (1) WO2015058960A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116270981B (en) 2016-01-15 2024-04-26 珠海贝海生物技术有限公司 Compositions and formulations comprising cabazitaxel and human serum albumin
US11413265B2 (en) 2018-04-20 2022-08-16 Zhuhai Beihai Biotech Co., Ltd. Formulations and compositions of Cabazitaxel

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MA23823A1 (en) 1995-03-27 1996-10-01 Aventis Pharma Sa NEW TAXOIDS, THEIR PREPARATION AND THE COMPOSITIONS CONTAINING THEM
FR2771092B1 (en) 1997-11-18 1999-12-17 Rhone Poulenc Rorer Sa PROCESS FOR THE PREPARATION OF DERIVATIVES OF THE TAXOID CLASS
FR2859996B1 (en) 2003-09-19 2006-02-03 Aventis Pharma Sa ACETONIC SOLVAT OF DIMETHOXY DOCETAXEL AND PROCESS FOR PREPARING THE SAME
FR2926551A1 (en) 2008-01-17 2009-07-24 Aventis Pharma Sa CRYSTALLINE FORMS OF DIMETHOXY DOCETAXEL AND METHODS FOR PREPARING SAME
KR20140018917A (en) 2011-04-12 2014-02-13 플러스 케미칼스, 에스.에이. Solid state forms of cabazitaxel and processes for preparation thereof
EP2548905A1 (en) 2011-07-18 2013-01-23 Bayer MaterialScience AG Method for activating double metal cyanide catalysts to produce polyether polyols
TWI526437B (en) 2011-09-09 2016-03-21 台灣神隆股份有限公司 Crystalline forms of cabazitaxel
JP6025861B2 (en) 2011-12-13 2016-11-16 アベンティス・ファーマ・ソシエテ・アノニム Crystal form of cabazitaxel and process for preparing it
CN104220431A (en) 2012-03-08 2014-12-17 伊瓦克斯国际有限责任公司 Solid state forms of cabazitaxel and processes for preparation thereof
CN102675257B (en) 2012-05-10 2014-07-02 上海金和生物技术有限公司 Cabazitaxel crystal and preparation method thereof
CN102746258B (en) * 2012-07-25 2015-02-04 重庆泰濠制药有限公司 Crystal forms of cabazitaxel and preparation method thereof

Also Published As

Publication number Publication date
EP2865674A1 (en) 2015-04-29
US20160257663A1 (en) 2016-09-08
KR20160074508A (en) 2016-06-28
CN105722832A (en) 2016-06-29
IL245259A0 (en) 2016-06-30
CA2928304A1 (en) 2015-04-30
MX2016005229A (en) 2016-08-11
EP3060555A1 (en) 2016-08-31
WO2015058960A1 (en) 2015-04-30
RU2016115559A (en) 2017-10-26
BR112016007595A2 (en) 2017-08-01
AU2014339221A1 (en) 2016-05-12
JP2016534066A (en) 2016-11-04

Similar Documents

Publication Publication Date Title
GB201421334D0 (en) Synthesis of aeizeolite
HRP20181710T1 (en) Use of benzimidazole-proline derivatives
GB201507664D0 (en) Composition & methods of screening
ZA201602198B (en) Preparation of hydroxy-benzylbenzene derivatives
ZA201602831B (en) Use of lactones
GB201319531D0 (en) Composition & methods of screening
IL240763B (en) Halogenopyrazoles as inhibitors of therombin
EP3003320A4 (en) Novel polymorph of regadenoson
HRP20182110T1 (en) Composition of tiacumicin compounds
IL245259A0 (en) Crystalline solvate forms of cabazitaxel
HK1216419A1 (en) Method of synthesis
IL240171A0 (en) Crystalline form of linaclotide
EP2947075A4 (en) Synthesis method of thiadiazolylamide derivative
HK1198422A1 (en) Novel uses of colossolactones
TWM475821U (en) Structure of mosquito-catch
TWM475524U (en) Structure of rivet-pulling
SG10201701021XA (en) Method of synthesis
PL3071575T3 (en) Preparation of normorphinans
GB201304608D0 (en) BenTime of Yisrael operable arrangement
GB201322922D0 (en) Synthesis of Polyoxometalates
PT2854831T (en) Manufacture of degarelix
GB201300370D0 (en) Method of calibrating asynchronies
GB201310660D0 (en) Synthesis of nucleosides
GB201301262D0 (en) Method of manufacture
GB201300647D0 (en) Crystallization